首页 › 软组织肉瘤 › 纽约州 › New York City
New York City NY 软组织肉瘤临床试验
19项针对 软组织肉瘤的研究正在 New York City及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma
招募中2 期
- Memorial Sloan Kettering Cancer Center, New York
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
A Study of CRD3874-SI in People With Solid Tumors
招募中1 期
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
招募中1/2 期
- Memorial Sloan Kettering Cancer Center, New York
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
招募中1/2 期
- New York University Langone Health, New York
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
招募中1/2 期
- Memorial Sloan Kettering Cancer Center, New York
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
招募中1 期
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
招募中1 期
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
招募中
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Actinium Therapy for Late-stage Aggressive Sarcomas
招募中1 期
- Memorial Sloane Kettering Cancer Center, New York
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
招募中观察性研究
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
招募中2 期
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
招募中1 期
- Zai Lab Site 02002, New York
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
招募中
- Memorial Sloan Kettering Cancer Center (All protocol activites), New York
A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg
招募中2 期
- Memorial Sloan Kettering Cancer Center, New York
A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma
招募中2 期
- Memorial Sloan Kettering Cancer Centre, New York
Phase II Trial of Lung Chemoemobolization
招募中2 期
- Memorial Sloan Kettering Cancer Center, New York
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
招募中1/2 期
- Memorial Sloan Kettering Cancer Center, New York
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
招募中1/2 期
- Memorial Sloan-Kettering Cancer Center, New York
其他城市的 软组织肉瘤试验
- Houston, TX32 项研究
- Boston, MA18 项研究
- St. Louis, MO14 项研究
- Columbus, OH13 项研究
- Los Angeles, CA13 项研究
- Washington, DC12 项研究
- Memphis, TN11 项研究
- Philadelphia, PA10 项研究
- Nashville, TN9 项研究
- Rochester, MN9 项研究
- Queens, NY9 项研究
- Aurora, CO9 项研究
New York City的其他研究
- 乳腺癌136 项研究
- 非小细胞肺癌121 项研究
- 癌症（所有类型）109 项研究
- 前列腺癌103 项研究
- 转移性癌症93 项研究
- 结直肠癌78 项研究
- 卵巢癌69 项研究
- 肺癌60 项研究
- 多发性骨髓瘤60 项研究
- 胰腺癌60 项研究
- 子宫内膜癌52 项研究
- 急性髓系白血病51 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。